ClinicalTrials.gg
RecruitingNCT05100966Updated Jul 1, 2025

FitJoints: Getting Fit for Hip and Knee Replacement

An interventional study of FitJoints Multi-modal Intervention in Hip Osteoarthritis and Knee Osteoarthritis, sponsored by McMaster University. Recruiting at 4 sites in Canada. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2025-07-01.

Sponsored by McMaster University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started Jun 2022; still recruiting 4 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
192
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 49 studies in Osteoarthritis, Hip with a site in Canada — 9 open to participants now, 13 under way, none of them phase 3. Osteoarthritis, Hip · Canada.

Planned enrollment
14th of 41
192 · median 96
Started
2022
with 1 other
No phase
32 of 49
8 open now
Primary completion
2026-03
later than 3 of 12 live
Registered
35th of 49
by date
Lead sponsor
6 of 49
McMaster University

Among the 49 studies in Osteoarthritis, Hip with a site in Canada, this one is the 14th largest by planned enrollment of the 41 interventional ones that give a count, is one of 2 that started in 2022, is one of 32 with no phase, reaches primary completion later than 3 of the 12 other live ones, and was the 35th registered.

Osteoarthritis, Hip

642 studies on the registry are indexed under Osteoarthritis, Hip; 120 are open to participants now.

Browse Osteoarthritis, Hip studies →

Open to participants now

9 of the 49 studies in Osteoarthritis, Hip with a site in Canada are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 86 Osteoarthritis, Hip studies recruiting now, 53 (62%) set no upper age limit and 7 (8%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 49 studies in Osteoarthritis, Hip with a site in Canada, or all of them as a file.
02

Study summary

Total hip or knee replacement is an important and cost-effective surgical intervention to relieve pain and improve independence and function in patients with osteoarthritis. The number of people waiting for elective surgeries has spiked in the COVID-19 pandemic. Prior to COVID-19, up to 40% of patients receiving joint replacement were frail and this number is rapidly increasing with longer wait-times and deconditioning associated with COVID-19 physical distancing. There is an urgent need to be responsive to the evolving challenges of healthcare. The proposed study is the first multi-site randomized controlled trial (RCT) to examine whether a multimodal frailty reduction intervention before surgery will improve postsurgical outcomes for this population. The COVID-19 adapted hybrid model includes a multimodal frailty intervention that may be implemented either in person or virtually and is aligned with international consensus guidelines on frailty reduction.

To utilize the FitJoints multimodal frailty intervention to build resilience of patients undergoing joint replacement surgery to improve post-operative outcomes. The investigators hypothesize the FitJoints multimodal frailty intervention, with exercise, nutrition and medication optimization, will reduce frailty and pain while improving function and quality of life.

Building upon the success of the FitJoints feasibility study (n=69) in Hamilton, Ontario, in the proposed multi-site RCT (n=192), older adults (≥60 years) undergoing hip or knee joint replacement surgery who are frail will be randomized to either the 3 to 6-months of multimodal intervention or usual care until the date of their surgery at multiple sites (Hamilton Health Sciences \& St Joseph's Healthcare Hamilton, ON; London Health Science Centre, London, ON; Foothills Hospital, Calgary, AB),The FitJoints evidence-based, multimodal intervention includes a hybrid model that can be implemented either in person or virtually:

  1. Physiotherapist supported multi-component exercise program
  2. Nutrition and protein optimization including dietary counseling
  3. Medication review with prescribing recommendations
03

Conditions studied

  • Hip Osteoarthritis
  • Knee Osteoarthritis

Keywords

  • Frail elderly
  • Arthroplasty
  • Pre-rehabilitation
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pre-frail (score of 1 or 2) or frail (score of 3-5)
  • ≥ 60 years old
  • Receiving elective unilateral total hip or knee replacement
  • Waiting time for surgery is estimated to be between 4 to 15 months

Exclusion criteria

Exclusion Criteria:

  • Renal disorder
  • A neuromuscular disorder
  • Active cancer
  • Inflammatory arthritis
  • Unable to speak or understand English and has no caregiver for translation
  • Participating in another trial that involves protein supplementation
  • Participating in an exercise program
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
192 participants (estimated)

Study arms

  • No intervention
    Usual Care

    Participants in the control arm will receive usual care which involves patient education that all participants who are scheduled for hip/knee replacement receive at the arthroplasty centre. This may include recommendations to attend fitness classes or discuss nutrition tips and smoking cessation initiatives with their family doctor or other healthcare provider before surgery.

  • Active comparator
    FitJoints Multi-modal Intervention

    Other: FitJoints Multi-modal Intervention

Interventions

  • OtherFitJoints Multi-modal Intervention

    Exercise: The study physiotherapist will prescribe an exercise program tailored to the participant's individual ability and preference with functional movements to mimic activities of daily living. Nutritional consultation and protein supplement: The site research assistant will coach participants to improve their nutrition, determine their daily protein target, and provide educational tools on how to achieve their target. Protein supplements will be provided to participants. Vitamin D: Participants will be provided with vitamin D3 (1000 IU) tablets to reduce the risk of falls and to preserve muscle strength and functional ability. They will be instructed to take one tablet daily for the duration of the intervention period. Medication optimization: The study pharmacist will conduct a medication review and provide, if required, recommendations for medication optimization.

06

What researchers measure

Primary outcomes

  1. Between-group Difference in Physical Performance

    Assessed by the Short Physical Performance Battery (SPPB), which consists of the following sub-components: * 4-meter walk test (walking speed): measured in seconds, scored 0 to 4 * Chair rise: the ability to rise from a chair without arms: measured in seconds, scored 0 to 4 * Standing balance test: measured in seconds, scored 0 to 4 Sub-component scores will be aggregated to produce an overall SPPB score, with higher scores indicating lower level of frailty \[range 0-12\].

    Time frame: 3-months post-operative

Secondary outcomes

  1. Between-group Difference in Frailty

    Assessed by the Fit-Frailty Index. Higher scores indicate greater degree of frailty \[range 0-1\].

    Time frame: 3-months post-operative

  2. Between-group Difference in Knee Function/Pain

    Patient-reported knee function/pain, assessed by the Oxford Knee Score. Higher scores indicate better knee functionality \[range 0-48\].

    Time frame: 3-months post-operative

  3. Between-group Difference in Hip Function/Pain

    Patient-reported hip function/pain, assessed by the Oxford Hip Score. Higher scores indicate better hip functionality \[range 0-48\].

    Time frame: 3-months post-operative

  4. Between-Group Difference in Instrumental Activities of Daily Living

    Ability to carry out instrumental activities of daily living as operationalized by the Older American Resources \& Services (OARS) questionnaire. Higher scores indicate greater ability to perform instrumental activities of daily living \[range 0-14\].

    Time frame: 3-months post-operative

  5. Between-group Difference in Physical Activities of Daily Living

    Ability to carry out physical activities of daily living as operationalized by the Older American Resources \& Services (OARS) questionnaire. Higher scores indicate greater ability to perform physical activities of daily living \[range 0-14\].

    Time frame: 3-months post-operative

  6. Between-group difference in Sarcopenia

    Assessed by the SARC-F - Self-reported strength, assistance with walking, rising from a chair, climbing stairs and falls. Higher scores indicate greater level of sarcopenia, with scores equal to or greater than 4 predictive of sarcopenia and poorer outcomes \[range 0-10\].

    Time frame: 3-months post-operative

  7. Between-group Difference in Nutrition

    Assessed by the Mini Nutritional Assessment (MNA). Higher scores indicate better nutritional status (\<17 malnourished, 17-23.5 at risk of malnutrition, 24-30 normal nutritional status) \[range 0-30\].

    Time frame: 3-months post-operative

  8. Between-group Difference in Cognition

    Ottawa-3DY-cognitive assessment - recall of day of week, date, year, spell WORLD backwards. Score of 4 indicates normal mental status, \<4 indicates impaired mental status \[range 0-4\].

    Time frame: 3-months post-operative

  9. Between-group Difference in Health-Related Quality of Life

    Quality of life questionnaire (EQ-5D-5L) which consists of 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension in the EQ-5D-5L has five response levels: no problems (Level 1); slight; moderate; severe; and extreme problems (Level 5). There are 3,125 possible health states defined by combining one level from each dimension, ranging from 11111 (full health) to 55555 (worst health).

    Time frame: 3-months post-operative

  10. Between-group Difference in Number of Hospitalizations

    Number of hospitalizations will be recorded. Higher numbers of hospitalizations indicates higher healthcare utilization.

    Time frame: 3-months post-operative

  11. Between-group Difference in Number of Emergency Department Visits

    Number of emergency department visits will be recorded. Higher number of emergency department visits indicates higher healthcare utilization.

    Time frame: 3-months post-operative

  12. Between-group Difference in Number of Visits to Physicians/Healthcare Professionals

    Number of visits to physicians and other healthcare professionals will be recorded. Higher number of visits indicates higher healthcare utilization.

    Time frame: 3-months post-operative

  13. Between-group Difference in Number of Post-operative Complications

    Any post-op complications (e.g. number of infections, peri-prosthetic fractures, bleeding) will be recorded.

    Time frame: 3-months post-operative

07

Study locations

1 of 4 sites recruiting
  • Foothill Medical Centre - Alberta Health Services
    Calgary, Alberta, Canada
    Not yet recruiting
    • Prism Schneider, MD, FRCSC · Principal investigator
  • Juravinski Hospital - Hamilton Health Sciences
    Hamilton, Ontario, Canada
    Recruiting
    • Mitchell Winemaker, MD, FRCSC · Principal investigator
  • St. Joseph's Healthcare
    Hamilton, Ontario, Canada
    Not yet recruiting
    • Anthony Adili, MD, FRCSC · Principal investigator
  • University Hospital - London Health Sciences Centre
    London, Ontario, Canada
    Not yet recruiting
    • Emil Schemitsch, MD, FRCSC · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2022 (actual). Primary completion is estimated for Mar 2026, 45 months after the start.

Of 201 non-industry interventional studies with no phase under Osteoarthritis, Hip, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 45 months is above that.

Counting every sponsor, half of 227 studies reached it within 29 months; a quarter within 14 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 27, 2021
First posted
Oct 29, 2021
StartActual
Jun 14, 2022
Primary completionEst.
Mar 2026
CompletionEst.
Mar 2026
Last update
Jul 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05100966
Collaborators
Hamilton Health Sciences Corporation, St. Joseph's Health Care London, London Health Sciences Centre, Alberta Health services
Responsible party
Alexandra Papaioannou (Professor, Department of Medicine, McMaster University) — Principal investigator
First posted
Oct 29, 2021
Start date
Jun 14, 2022
Primary completion
Mar 2026 (estimated)
Completion
Mar 2026 (estimated)
Last update
Jul 1, 2025

Study contacts

Alexandra Papaioannou, MD, MSc
Contact
papaioannou@hhsc.ca
(905) 521-2100 ext. 77715
George Ioannidis, MSc, PhD
Contact
ioannidis@hhsc.ca
Alexandra Papaioannou
principal investigator · McMaster University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion